NEW YORK, Jan. 22, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Injectable Drug Delivery to 2020
http://www.reportlinker.com/p01963415/Injectable-Drug-Delivery-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology
The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. This report examines the key therapeutic, product, market and regulatory factors for injectable drugs across ten major disease and therapeutic classes, providing essential insight and forecasts into the implications of this evolving landscape.
Highlights
- Analyzes and evaluates the shifting landscape for injectable drug delivery and assesses the market impact of new and emerging injectable drug products by therapeutic indication
- Analyzes syringe and injector device designs, feature/functionality, product branding, competing technologies and market development issues
- Provides detailed descriptions of key injectable drug therapeutic market segments, market demographics, and business strategies
- Forecasts Injectable drug product demand by indication and therapy to 2020
- Profiles leading injection device companies, their product development activities, business strategies, and corporate alliances and affiliations
Executive Summary
Injectable Drug Delivery Market Dynamics
The Injectable Drug Ecosystem
Injectable Drug Demand Drivers
Drug Development Factors
Market Factors
Technology Factors
Competitive Landscape
Autoinjectors
Needle-free Injectors
Pen Injectors
Prefilled Syringes
Safety Syringes
Risks and Opportunities
Injectable Drug Device Selection Criteria
Stability and Material Selection Issues
Single vs Multi-Dose Devices
Lyophilized Drugs/Reconstitution
Syringe Safety/Sharps Protection
Needle Configuration Strategies
Disposable Drug Cartridges
Human Engineering/Ergonomics
Branding/Private Labeling
Injectable Drug Delivery – Device Segments
Autoinjectors
Autoinjector-specific Selection Factors
Part Counts and Device Cost
Safety Features
Needle Shielding
Needle Insertion Depth
Failsafe Activation
Dose Inspection/Injection Confirmation
Autoinjector Device Categories
Reusable Autoinjectors
Disposable Autoinjectors
Product Specific Autoinjectors
Drugs and Therapeutic Segments
Needle-free InjectorsDevice CategoriesEnd User/Practitioner/Mass Immunization InjectorsPrefilled Disposable ModelsRefillable Cartridge DesignsNeedle-free Injector-specific Selection FactorsEnergy SourceInjection Site Selection
Pen Injectors
Pen Injector Device Categories
Standardized Pen Platforms
Custom Pen Designs
Reusable Pens
Prefilled Pen Cartridges
Disposable Pens
Dual Chamber Pens
Branded Drug/Pen Injector Product by Therapeutic Segment
Prefilled SyringesPrefilled Syringe Device CategoriesGlass Prefilled SyringesPrefillable Glass Syringe Manufacturers and Branded DevicesBranded Drug/Prefilled Glass Syringe Products by Therapeutic SegmentPlastic Prefilled SyringesBranded Prefillable Plastic SyringesDrugs and Therapeutic SegmentsPrefillable Safety SyringesPrefilled Syringe-specific Selection FactorsPFS Manufacturing FactorsFill-and-Finish Operations
Safety Syringes
Safety Syringe Device Categories
Prefillable Integrated Safety Syringes
Non-Prefillable Integrated Safety Syringes
Retractable Needle
Manually Retractable
Automatic Retractable
Sliding Sheath
Injectable Drug Delivery – Therapeutic Segment Analysis & Forecasts
Anaphylaxis
Anticoagulants
Antivirals
Autoimmune Diseases
Emergency Medicine
Hematopoietics
Hormone Replacement
Metabolic Diseases
Neurology
Reproductive Health
Vaccines
Injectable Drug Therapeutics - Market Factors
Regulatory Factors and Issues
FDA Regulations
Regulating Combination Products
Sharps Legislations
Growth and Diversity of Safety Syringes
Sharps Disposal
Clinical Trial Factors
Managed Care and Healthcare Economics
Company Profiles
To order this report: Injectable Drug Delivery to 2020 http://www.reportlinker.com/p01963415/Injectable-Drug-Delivery-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article